A comprehensive view of U.S. Food and Drug Administration (FDA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves subcutaneous administration of Takeda’s ENTYVIO (vedolizumab) for maintenance therapy in moderately to severely active Crohn’s Disease
Published: April 19, 2024 by Business Wire
Vanda Pharmaceuticals thwarts a hostile takeover bid from Future Pak by implementing a shareholder rights plan or 'poison pill' strategy; the bid follows FDA approval for the expansion of its antipsychotic drug Fanapt
Published: April 19, 2024 by FiercePharma
High demand for injectable weight-loss drugs has led to supply issues, with most varieties listed in short supply by the FDA; Eli Lilly reports shortages of its Zepbound and Mounjaro could last until 2025
Published: April 19, 2024 by CBS - 12 WJTV (Jackson, MS)
FDA approves Roche's oral Alecensa for ALK-positive early-stage lung cancer treatment following successful Phase 3 trial; trial results show Alecensa reduced the risk of disease recurrence or death by 76%
Published: April 19, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
FDA grants fast track designation to Asklepios BioPharmaceutical's AB-1002, a gene therapy for adults with non-ischemic cardiomyopathy and Class III heart failure symptoms; the therapy is currently in Phase 2 trials
Published: April 18, 2024 by Bayer AG

Ask us about our Logistic & Supply Chain market view

Trending Chart

Interactive chart with headline count